Articles

1. Neurological aspects of HTLV-1 infection: symptoms in apparently asymptomatic carriers

   • Qesya Rodrigues Ferreira
   • Ana Flávia Novaes
   • Davi Tanajura Costa

   OriginalPaper 23 April 2024

   

2. Mapping ACE2 and TMPRSS2 co-expression in human brain tissue: implications for SARS-CoV-2 neurological manifestations

   • Tulika Gupta
   • Munish Kumar
   • Ranjana Bharti

   OriginalPaper 10 April 2024

   

3. Modeling HIV-1 infection and NeuroHIV in hiPSCs-derived cerebral organoid cultures

   • Martina Donadoni
   • Senem Cakir
   • Ilker K. Sariyer

   OriginalPaper Open access 10 April 2024

   

4. Differences in neuroinflammation in people who started antiretroviral treatment during primary versus chronic HIV infection: an 18kDa Translocator protein (TSPO) positron emission tomography (PET) study

   • Jasmini Alagaratnam
   • John P. Thornhill
   • Alan Winston

   OriginalPaper Open access 04 April 2024

   

5. Clinical characteristics and outcomes of COVID-19-associated encephalopathy in children

   • Li Li
   • Hongmei Liao
   • Ke Jin

   OriginalPaper 03 April 2024

   

6. Implications of vascular depression for successful cognitive aging in HIV Disease

   • Andrea I. Mustafa
   • Ilex Beltran-Najera
   • Steven Paul Woods

   OriginalPaper 28 March 2024

   

7. Progressive multifocal leukoencephalopathy associated with systemic lupus erythematosus: longitudinal observation of lymphocytes, JC virus in cerebrospinal fluid, and brain magnetic resonance imaging

   • Hidetada Yamada
   • Megumi Toko
   • Hirofumi Maruyama

   Case Report Open access 19 March 2024

   

8. RNA-Seq time-course analysis of neural precursor cell transcriptome in response to herpes simplex Virus-1 infection

   • Joel A. Wood
   • Srilakshmi Chaparala
   • Leonardo D’Aiuto

   OriginalPaper Open access 13 March 2024

   

9. Cerebrospinal Fluid Biomarkers of Symptomatic Neurosyphilis in People With HIV Compared with Uninfected Individuals

   • Sérgio Monteiro de Almeida
   • José Tresoldi Neto
   • Fausto Guimarães

   OriginalPaper 12 March 2024

   

10. Tryptophan-kynurenine metabolic pathway and daytime dysfunction in women with HIV

    • Eran Frank Shorer
    • Leah H Rubin
    • Raha M Dastgheyb

    OriginalPaper 12 March 2024

    

11. The synergistic effect of insomnia and depression on risk of herpes zoster

    • Hsueh-Ching Wu
    • Chia-Ling Lin
    • Wu-Chien Chien

    OriginalPaper 21 February 2024

    

12. HIV-1 mRNA knockdown with CRISPR/CAS9 enhances neurocognitive function

    • Kristen A. McLaurin
    • Hailong Li
    • Rosemarie M. Booze

    OriginalPaper Open access 14 February 2024 Pages: 71 - 85

    

13. Correction to: Reduced neuronal population in the dorsolateral prefrontal cortex in infant macaques infected with simian immunodeficiency virus (SIV)

    • Alexandra Haddad
    • Brittany Voth
    • Mark W. Burke

    Correction Open access 01 February 2024 Pages: 100 - 100

14. Simian varicella virus infection and reactivation in rhesus macaques trigger cytokine and Aβ40/42 alterations in serum and cerebrospinal fluid

    • Christy S. Niemeyer
    • Vicki Traina-Dorge
    • Andrew N. Bubak

    Short Communication 07 March 2024 Pages: 86 - 99

    

15. Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice

    • Kara M. Rademeyer
    • Sara R. Nass
    • MaryPeace McRae

    OriginalPaper 27 January 2024 Pages: 1 - 21

    

16. Understanding the link between neurotropic viruses, BBB permeability, and MS pathogenesis

    • Annu Rani
    • Süleyman Ergün
    • Hem Chandra Jha

    Mini-Review 08 January 2024 Pages: 22 - 38

    

17. Correction: GP120 and tenofovir alafenamide alter cannabinoid receptor 1 expression in hippocampus of mice

    • Jacqueline Renee Kulbe
    • Alexandra Anh Le
    • Jerel Adam Fields

    Correction Open access 04 January 2024 Pages: 101 - 102

    

18. SARS-CoV and SARS-CoV-2 display limited neuronal infection and lack the ability to transmit within synaptically connected axons in stem cell–derived human neurons

    • Jasmina M. Luczo
    • Sarah J. Edwards
    • Vinod Sundaramoorthy

    OriginalPaper Open access 03 January 2024 Pages: 39 - 51

    

19. Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 with Alzheimer’s/Parkinson’s diseases

    • Althaf Mahin
    • Sreelakshmi Pathappillil Soman
    • Chandran S. Abhinand

    OriginalPaper 02 January 2024 Pages: 57 - 70

    

20. Reactivation of varicella zoster virus following trigeminal schwannoma resection

    • Singh Deepak Kumar
    • Sinha Kshitij
    • Singh Nirbhay

    OriginalPaper 14 December 2023 Pages: 52 - 56

    

21. Correction: Performance of the national institute of infectious diseases disability scale in HTLV-1-associated myelopathy/tropical spastic paraparesis

    • Felipe R. Schmidt
    • Evandro S. F. Coutinho
    • Abelardo Q. C. Araujo

    Correction 30 November 2023 Pages: 734 - 734

22. Is there a connection between neurocognitive profile in treatment naïve non-cirrhotic HCV patients and level of systemic inflammation?

    • Maja Ružić
    • Natalija Rajić
    • Vojislava Bugarski Ignjatović

    OriginalPaper 10 November 2023 Pages: 723 - 730

23. The relationship between synaptodendritic neuropathology and HIV-associated neurocognitive disorders is moderated by cognitive reserve

    • Arin Fisher
    • David J. Moore
    • Erin E. Sundermann

    OriginalPaper 09 November 2023 Pages: 713 - 722

    

24. Acute cerebellitis following COVID-19 infection associated with autoantibodies to glutamate receptors: a case report

    • Takuya Watanabe
    • Yuki Kakinuma
    • Ryuta Kinno

    Case Report Open access 06 November 2023 Pages: 731 - 733

    

25. Predictors of hippocampal tauopathy in people with and at risk for human immunodeficiency virus infection

    • Sophie Nader
    • Esma Karlovich
    • Susan Morgello

    OriginalPaper 05 November 2023 Pages: 647 - 657

    

26. Characterizing Epstein-Barr virus infection of the central nervous system in Zambian adults living with HIV

    • Kalo Musukuma-Chifulo
    • Musie Ghebremichael
    • Omar K. Siddiqi

    OriginalPaper 30 October 2023 Pages: 706 - 712

    

27. Disruption of blood–brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins

    • Yuqing Sun
    • Miaotian Cai
    • Yulin Zhang

    Review 29 October 2023 Pages: 658 - 668

    

28. Genetic polymorphisms in innate immunity genes influence predisposition to tick-borne encephalitis

    • Andrea Fortova
    • Andrey V. Barkhash
    • Daniel Ruzek

    OriginalPaper Open access 28 October 2023 Pages: 699 - 705

29. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China

    • Siyuan Fan
    • Mange Liu
    • Hongzhi Guan

    OriginalPaper 28 October 2023 Pages: 692 - 698

    

30. Immune response to COVID-19 vaccines among people living with human T-cell lymphotropic virus type 1 infection: a retrospective cohort study from Iran

    • Reza Jafarzadeh Esfehani
    • Zohreh Vahidi
    • Mohammad Reza Hedayati-Moghaddam

    SI: HTLV-1 Revisited 23 October 2023

31. Application of VirCapSeq-VERT and BacCapSeq in the diagnosis of presumed and definitive neuroinfectious diseases

    • Abhilasha P. Boruah
    • Adam Kroopnick
    • Kiran T. Thakur

    OriginalPaper 18 October 2023 Pages: 678 - 691

32. Correction to: The anti-cancer drug Sunitinib promotes autophagy and protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. Journal of NeuroVirology 2017

    • Eliezer Masliah

    Letter to the Editor 09 October 2023 Pages: 644 - 644

    

33. Correction: Tat expression led to increased histone 3 tri-methylation at lysine 27 and contributed to HIV latency in astrocytes through regulation of MeCP2 and Ezh2 expression

    • Ying Liu
    • Yinghua Niu
    • Johnny J. He

    Correction 06 October 2023 Pages: 645 - 645

    

34. GP120 and tenofovir alafenamide alter cannabinoid receptor 1 expression in hippocampus of mice

    • Jacqueline Renee Kulbe
    • Alexandra Anh Le
    • Jerel Adam Fields

    OriginalPaper Open access 06 October 2023 Pages: 564 - 576

    

35. Abstracts of the 19th International Symposium on NeuroVirology October 2–5, 2023 Montreal, Quebec, Canada

    Abstracts 18 September 2023 Pages: 1 - 41

36. Sex differences in cognitive function among people with HIV-1 clade C infection in Northern India

    • Anchal Sharma
    • Manju Mohanty
    • Mahendra Kumar

    OriginalPaper 12 September 2023 Pages: 614 - 625

    

37. Association of cytokine gene polymorphisms with peripheral neuropathy susceptibility in people living with HIV in Greece

    • Ioannis Nikolaidis
    • Maria–Valeria Karakasi
    • Pavlos Nikolaidis

    OriginalPaper 11 September 2023 Pages: 626 - 639

38. HSV-1 latency-associated transcript miR-H3 and miR-H4 target STXBP1 and GABBR2 genes

    • Karrar Mahmood Shaker AL-Khfaji
    • Nika Kooshki Zamani
    • Ehsan Arefian

    OriginalPaper 05 September 2023 Pages: 669 - 677

    

39. Long-term survival from progressive multifocal leukoencephalopathy in living-donor liver transplant recipient with preformed donor-specific antibody

    • Shuhei Egashira
    • Akatsuki Kubota
    • Tatsushi Toda

    Case Report Open access 05 September 2023 Pages: 519 - 523

    

40. Revisiting JC virus and progressive multifocal leukoencephalopathy

    • Angela Rocchi
    • Ilker K. Sariyer
    • Joseph R. Berger

    Review 02 September 2023 Pages: 524 - 537

    

41. Combined effects of loneliness and inflammation on depression in people with HIV

    • Mariam A. Hussain
    • C. Wei-Ming Watson
    • Jennifer E. Iudicello

    OriginalPaper Open access 31 August 2023 Pages: 538 - 554

    

42. Guillain-Barré syndrome as clinical presentation of a recently acquired hepatitis C

    • Filomena Boccia
    • Letizia Lucia Florio
    • Rosa Zampino

    Case Report Open access 30 August 2023 Pages: 640 - 643

    

43. Advances in HIV therapeutics and cure strategies: findings obtained through non-human primate studies

    • Alison R. Van Zandt
    • Andrew G. MacLean

    Review 27 August 2023 Pages: 389 - 399

    

44. Immune-mediated cerebellitis following SARS-CoV-2 infection—a case report and review of the literature

    • Florence Plumacker
    • Nicolas Lambert
    • Pierre Maquet

    Case Report 17 August 2023 Pages: 507 - 518

45. Evolving etiologies, comorbidities, survival, and costs of care in adult encephalitis

    • J. A. Bakal
    • R. Rivera
    • C. Power

    OriginalPaper 15 August 2023 Pages: 605 - 613

    

46. Detection of disease-associated microglia among various microglia phenotypes induced by West Nile virus infection in mice

    • Passawat Thammahakin
    • Keisuke Maezono
    • Shintaro Kobayashi

    OriginalPaper 08 August 2023 Pages: 367 - 375

    

47. Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo

    • Sanaz Ahmadi Ghezeldasht
    • Hamid Reza Bidkhori
    • Seyed Abdolrahim Rezaee

    SI: HTLV-1 Revisited 02 August 2023

    

48. Correction: Frequency of varicella zoster virus DNA in human adrenal glands

    • Hussain Badani
    • Teresa White
    • Maria A. Nagel

    Correction 01 August 2023 Pages: 376 - 376

49. Serum of COVID-19 patients changes neuroinflammation and mitochondrial homeostasis markers in hippocampus of aged rats

    • Yorran Hardman A. Montenegro
    • Larissa Daniele Bobermin
    • Guilhian Leipnitz

    OriginalPaper 27 July 2023 Pages: 577 - 587

    

50. Metagenomic search of viral coinfections in herpes simplex encephalitis patients

    • Karol Perlejewski
    • Marek Radkowski
    • Tomasz Laskus

    OriginalPaper Open access 25 July 2023 Pages: 588 - 597